Zapolnik相关文献与解析，生知库 | 链接生命科学的每一步

Herpes Zoster: Risk Factors for Occurrence, Complications, and Recurrence with a Focus on Immunocompromised Patients

带状疱疹：发生、并发症和复发的风险因素，重点关注免疫功能低下患者

期刊:Diseases

影响因子:3

doi:10.3390/diseases13030071

Oleszko, Michał; Zapolnik, Paweł; Kmiecik, Wojciech; Czajka, Hanna

Trained Immunity, BCG and SARS-CoV-2 General Outline and Possible Management in COVID-19

训练免疫、卡介苗和SARS-CoV-2：COVID-19的一般概述和可能管理

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms24043218

Zapolnik, Paweł; Kmiecik, Wojciech; Mazur, Artur; Czajka, Hanna

Rotavirus Vaccination of Premature Newborns in the NICU: Evaluation of Vaccination Rates and Safety Based on a Single-Centre Study

早产儿在新生儿重症监护室接受轮状病毒疫苗接种：基于单中心研究的疫苗接种率和安全性评估

期刊:Vaccines

影响因子:3.4

doi:10.3390/vaccines11081282

Marcinek, Klaudia; Zapolnik, Paweł; Radziszewska, Renata; Ochoda-Mazur, Agnieszka; Czajka, Hanna; Pawlik, Dorota

微生物学

发表日期：2023

文献求助收藏

PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia

PP2A 是一种可通过 c-Myc/p21 轴决定人类和鼠类急性髓系白血病细胞命运的治疗靶向驱动因子

期刊:Blood

影响因子:21

doi:10.1182/blood.2020010344

Swagata Goswami, Rajeswaran Mani, Jessica Nunes, Chi-Ling Chiang, Kevan Zapolnik, Eileen Hu, Frank Frissora, Xiaokui Mo, Logan A Walker, Pearlly Yan, Ralf Bundschuh, Larry Beaver, Raymond Devine, Yo-Ting Tsai, Ann Ventura, Zhiliang Xie, Min Chen, Rosa Lapalombella, Alison Walker, Alice Mims, Karilyn

Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy

评估同种异体和自体膜结合IL-21扩增的NK细胞在慢性淋巴细胞白血病治疗中的应用

期刊:Blood Advances

影响因子:7.1

doi:10.1182/bloodadvances.2021005883

Yano, Max; Sharpe, Chia; Lance, J Rachel; Ravikrishnan, Janani; Zapolnik, Kevan; Mo, Xiaokui; Woyach, Jennifer A; Sampath, Deepa; Kittai, Adam S; Vasu, Sumithira; Bhat, Seema; Rogers, Kerry A; Lee, Dean A; Muthusamy, Natarajan; Byrd, John C

A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland-Evaluation of Antibody Concentrations

一项多中心、随机、双盲、安慰剂对照的 III 期临床试验，旨在评估在波兰 COVID-19 大流行期间，BCG 再次接种对有症状的医护人员中 SARS-CoV-2 感染发生率和严重程度的影响——抗体浓度评估

期刊:Vaccines

影响因子:3.4

doi:10.3390/vaccines11010075

Zapolnik, Paweł; Kmiecik, Wojciech; Nowakowska, Anna; Krzych, Łukasz Jerzy; Szymański, Henryk; Stopyra, Lidia; Jackowska, Teresa; Darmochwał-Kolarz, Dorota; Mazur, Artur; Czajka, Hanna

ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia

ROR1靶向免疫脂质体递送OSU-2S对t(1;19)(q23;p13)易位B细胞急性淋巴细胞白血病显示出选择性细胞毒性

期刊:Leukemia Research

影响因子:2.2

doi:10.1016/j.leukres.2022.106872

Goswami, Swagata; Chiang, Chi-Ling; Zapolnik, Kevan; Nunes, Jessica; Ventura, Ann; Mo, Xiaokui; Xie, Zhiliang; Lee, L James; Baskar, Sivasubramanian; Rader, Christoph; Byrd, John C; Phelps, Mitch; Bhatnagar, Bhavana; Muthusamy, Natarajan

A Multi-Center, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland-First Results

一项多中心、随机、双盲、安慰剂对照的 III 期临床试验，评估波兰 COVID-19 疫情期间重新接种 BCG 对有症状的医护人员中 SARS-CoV-2 感染发病率和严重程度的影响 - 初步结果

期刊:Vaccines

影响因子:

doi:10.3390/vaccines10020314

Hanna Czajka, Paweł Zapolnik, Łukasz Krzych, Wojciech Kmiecik, Lidia Stopyra, Anna Nowakowska, Teresa Jackowska, Dorota Darmochwał-Kolarz, Henryk Szymański, Igor Radziewicz-Winnicki, Artur Mazur

The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia

ROR1抗体药物偶联物huXBR1-402-G5-PNU可有效靶向ROR1阳性白血病

期刊:Blood Advances

影响因子:7.4

doi:10.1182/bloodadvances.2020003276

Eileen Y Hu ，Priscilla Do ，Swagata Goswami ，Jessica Nunes ，Chi-Ling Chiang ，Sara Elgamal ，Ann M Ventura ，Carolyn Cheney ，Kevan Zapolnik ，Erich Williams ，Rajeswaran Mani ，Frank Frissora ，Xiaokui Mo ，Lorenz Waldmeier ，Roger R Beerli ，Haiyong Peng ，Christoph Rader ，Meixiao Long ，Ulf Grawunder ，John C Byrd ，Natarajan Muthusamy

Herpes Zoster Vaccination: Insights into Efficacy, Safety, and Guidelines

带状疱疹疫苗：疗效、安全性和指南的见解

Herpes Zoster: Risk Factors for Occurrence, Complications, and Recurrence with a Focus on Immunocompromised Patients

带状疱疹：发生、并发症和复发的风险因素，重点关注免疫功能低下患者

Trained Immunity, BCG and SARS-CoV-2 General Outline and Possible Management in COVID-19

训练免疫、卡介苗和SARS-CoV-2：COVID-19的一般概述和可能管理

Rotavirus Vaccination of Premature Newborns in the NICU: Evaluation of Vaccination Rates and Safety Based on a Single-Centre Study

早产儿在新生儿重症监护室接受轮状病毒疫苗接种：基于单中心研究的疫苗接种率和安全性评估

PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia

PP2A 是一种可通过 c-Myc/p21 轴决定人类和鼠类急性髓系白血病细胞命运的治疗靶向驱动因子

Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy

评估同种异体和自体膜结合IL-21扩增的NK细胞在慢性淋巴细胞白血病治疗中的应用

一项多中心、随机、双盲、安慰剂对照的 III 期临床试验，旨在评估在波兰 COVID-19 大流行期间，BCG 再次接种对有症状的医护人员中 SARS-CoV-2 感染发生率和严重程度的影响——抗体浓度评估

ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia

ROR1靶向免疫脂质体递送OSU-2S对t(1;19)(q23;p13)易位B细胞急性淋巴细胞白血病显示出选择性细胞毒性

A Multi-Center, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland-First Results

一项多中心、随机、双盲、安慰剂对照的 III 期临床试验，评估波兰 COVID-19 疫情期间重新接种 BCG 对有症状的医护人员中 SARS-CoV-2 感染发病率和严重程度的影响 - 初步结果

The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia

ROR1抗体药物偶联物huXBR1-402-G5-PNU可有效靶向ROR1阳性白血病